This program will include a discussion of offlabel treatment and investigational agents not approved by the FDA for use in the US and data that were presented in abstract form These data should be considered preliminary until published in a peerreviewed journal ID: 908524
Download Presentation The PPT/PDF document "Advances in Immunotherapy for Peanut All..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Advances in Immunotherapy for Peanut Allergy
Slide2This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form.
These data should be considered preliminary until published in a peer-reviewed journal.
Slide3Introduction to Peanut Allergy Immunotherapy
Slide4OIT Phase 2 Study
Design
Slide5OIT Phase 2 Study
Results
Slide6OIT Phase 3 Study
Efficacy
Slide7OIT Phase 3 Study
Safety
Slide8EPIT Phase 3 Study
Design
Slide9EPIT Phase 3 Study
Results
Slide10Balancing Safety and Efficacy
Slide11Shared Decision-Making
Slide12Conclusions and Key Takeaways
Slide13